Cargando…
Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer, which causes ~800,000 deaths annually world-wide. Immune checkpoint inhibitor (ICI) has reformed cancer therapy and achieved unprecedented results in various malignancies, including HCC. However, the respo...
Autores principales: | Deng, Zenghua, Huang, Kanghua, Liu, Dongfang, Luo, Nan, Liu, Tingting, Han, Long, Du, Dexiao, Lian, Dongbo, Zhong, Zhaohui, Peng, Jirun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694277/ https://www.ncbi.nlm.nih.gov/pubmed/34956967 http://dx.doi.org/10.2147/JHC.S337067 |
Ejemplares similares
-
DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer
por: Deng, Zenghua, et al.
Publicado: (2021) -
Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma
por: Huang, Kanghua, et al.
Publicado: (2018) -
EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Shu, Yang, et al.
Publicado: (2022) -
Comprehensive Analysis of NABP2 as a Prognostic Biomarker and Its Correlation with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Bowen, et al.
Publicado: (2023) -
ANP32 Family as Diagnostic, Prognostic, and Therapeutic Biomarker Related to Immune Infiltrates in Hepatocellular Carcinoma
por: Liu, Xuxu, et al.
Publicado: (2022)